JM

John McKearn

Venture Capital / BioPharma R&D

United States

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $1,000,000.00

Skills

Biotechnology
Life Sciences
Pharmaceuticals
Drug Discovery
Immunology
Drug Development
Lifesciences
Pharmaceutical Industry
Medicinal Chemistry
Clinical Development
Genomics
Oncology
Technology Transfer
Biopharmaceuticals
Patents

Education

Investments

OncoResponse

Series D

Total Funding: $110M

Bonum Therapeutics

Series A

Total Funding: $93M

Good Therapeutics

Series B

Total Funding: $30M

Wugen

Series B

Total Funding: $170M

Allakos

Series A

Total Funding: $290M

Arch Oncology

Series A

Total Funding: $86M

Otonomy

Series B

Total Funding: $180M

ZS Pharma

Series C

Total Funding: $100M

Lumena Pharmaceuticals

Series A

Total Funding: $68M

Work Experience

RiverVest Venture Partners

2008

  • Managing Director

    2008

PennyHead LLC

2004

  • President

    2004

    Life Sciences / BioPharmaceutical Consulting

IDM Pharma

2000 - 2009

  • Board Member

    2000 - 2009

Kalypsys

2003 - 2006

  • CSO, President & CEO

    2003 - 2006

Pharmacia

2000 - 2003

  • Sr VP of Discovery Research

    2000 - 2003

Searle

1987 - 2000

  • Research

    1987 - 2000